Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding

被引：0
作者：
Nicola Laurieri
Akane Kawamura
Isaac M Westwood
Amy Varney
Elizabeth Morris
Angela J Russell
Lesley A Stanley
Edith Sim
机构：
[1] University of Oxford,Department of Pharmacology
[2] Chemistry Research Laboratory,Department of Chemistry
[3] University of Oxford,Divisions of Structural Biology and Cancer Therapeutics
[4] The Institute of Cancer Research,Faculty of Science, Engineering and Computing
[5] Chester Beatty Laboratories,undefined
[6] Consultant in Investigative Toxicology,undefined
[7] Kingston University,undefined
来源：
BMC Pharmacology and Toxicology | / 15卷
关键词：
Arylamine ; -acetyltransferase; (MOUSE)NAT1; (MOUSE)NAT2; Substrate specificity; Inhibitor selectivity; Structural docking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 282 条
[1]  
Weber WW(1985) acetylation pharmacogenetics Pharmacol Rev 37 25-79
[2]  
Hein DW(2014)Arylamine Br J Pharmacol 171 2705-2725
[3]  
Sim E(1990) acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery DNA Cell Biol 9 193-203
[4]  
Abuhammad A(1994)Human arylamine Biochem J 297 441-445
[5]  
Ryan A(2009) acetyltransferase genes: isolation, chromosomal localization, and functional expression Expert Opin Drug Metab Toxicol 5 353-366
[6]  
Blum M(2000)Chromosomal localization of human genes for arylamine Cancer Epidemiol Biomarkers Prev 9 29-42
[7]  
Grant DM(1990) acetyltransferase J Biol Chem 265 4630-4634
[8]  
McBride W(2005) acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine Biochem Pharmacol 69 347-359
[9]  
Heim M(2007)Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms J Biol Chem 282 30189-30197
[10]  
Meyer UA(2008)Cloning and expression of cDNAs for polymorphic and monomorphic arylamine Toxicology 254 170-183
12345678910